Följ
Sandra Segura-Bayona
Sandra Segura-Bayona
Postdoctoral fellow, the Francis Crick Institute, London, UK
Verifierad e-postadress på CRICK.AC.UK
Titel
Citeras av
Citeras av
År
MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5′ end resection
V Boersma, N Moatti, S Segura-Bayona, MH Peuscher, J Van der Torre, ...
Nature 521 (7553), 537-540, 2015
2942015
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
CF Houlihan, N Vora, T Byrne, D Lewer, G Kelly, J Heaney, S Gandhi, ...
The Lancet 396 (10246), e6-e7, 2020
2482020
FANCJ promotes DNA synthesis through G‐quadruplex structures
P Castillo Bosch, S Segura‐Bayona, W Koole, JT van Heteren, JM Dewar, ...
The EMBO journal 33 (21), 2521-2533, 2014
1402014
GEMC 1 is a critical regulator of multiciliated cell differentiation
B Terré, G Piergiovanni, S Segura‐Bayona, G Gil‐Gómez, SA Youssef, ...
The EMBO journal 35 (9), 942-960, 2016
922016
Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD
G Hewitt, V Borel, S Segura-Bayona, T Takaki, P Ruis, R Bellelli, ...
Molecular cell 81 (4), 767-783. e11, 2021
842021
SLX4IP antagonizes promiscuous BLM activity during ALT maintenance
S Panier, M Maric, G Hewitt, E Mason-Osann, H Gali, A Dai, A Labadorf, ...
Molecular cell 76 (1), 27-43. e11, 2019
772019
PARP-1/PARP-2 double deficiency in mouse T cells results in faulty immune responses and T lymphomas
J Navarro, B Gozalbo-López, AC Méndez, F Dantzer, V Schreiber, ...
Scientific reports 7 (1), 41962, 2017
602017
Tousled-like kinases stabilize replication forks and show synthetic lethality with checkpoint and PARP inhibitors
SB Lee, S Segura-Bayona, M Villamor-Payà, G Saredi, MAM Todd, ...
Science advances 4 (8), eaat4985, 2018
472018
RTEL1 regulates G4/R-loops to avert replication-transcription collisions
P Kotsantis, S Segura-Bayona, P Margalef, P Marzec, P Ruis, G Hewitt, ...
Cell reports 33 (12), 2020
452020
The Tousled-like kinases regulate genome and epigenome stability: implications in development and disease
S Segura-Bayona, TH Stracker
Cellular and molecular life sciences 76 (19), 3827-3841, 2019
442019
LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells
JP Cebrià-Costa, L Pascual-Reguant, A Gonzalez-Perez, ...
Oncogene 39 (1), 79-121, 2020
422020
POLQ seals post-replicative ssDNA gaps to maintain genome stability in BRCA-deficient cancer cells
O Belan, M Sebald, M Adamowicz, R Anand, A Vancevska, J Neves, ...
Molecular cell 82 (24), 4664-4680. e9, 2022
412022
Molecular basis of tousled-like kinase 2 activation
GB Mortuza, D Hermida, AK Pedersen, S Segura-Bayona, ...
Nature communications 9 (1), 2535, 2018
302018
Tousled-like kinases suppress innate immune signaling triggered by alternative lengthening of telomeres
S Segura-Bayona, M Villamor-Payà, CSO Attolini, LM Koenig, ...
Cell Reports 32 (5), 2020
272020
Differential requirements for Tousled-like kinases 1 and 2 in mammalian development
S Segura-Bayona, PA Knobel, H Gonzalez-Buron, SA Youssef, ...
Cell Death & Differentiation 24 (11), 1872-1885, 2017
272017
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy
S Balestrini, MJ Koepp, S Gandhi, HM Rickman, GY Shin, CF Houlihan, ...
Epilepsy & Behavior 115, 107602, 2021
162021
A C-circle assay for detection of alternative lengthening of telomere activity in FFPE tissue
AI Idilli, S Segura-Bayona, TP Lippert, SJ Boulton
STAR protocols 2 (2), 100569, 2021
112021
SIRT1 regulates DNA damage signaling through the PP4 phosphatase complex
G Rasti, M Becker, BN Vazquez, M Espinosa-Alcantud, ...
Nucleic Acids Research 51 (13), 6754-6769, 2023
32023
Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling
S Segura-Bayona, M Villamor-Payà, CSO Attolini, TH Stracker
bioRxiv, 621409, 2019
32019
Maintaining oxidized H3 in heterochromatin is required for the oncogenic capacity of triple-negative breast cancer cells
G Serra-Bardenys, T Tian, E Blanco, J Querol, L Pascual-Reguant, ...
BioRxiv, 2020.01. 30.927038, 2020
12020
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20